Tucked away in the village of Leasowe, near Moreton on the Wirral peninsula west of Liverpool, the US pharmaceutical company Bristol Myers Squibb (BMS) is building a new £35m glass-clad laboratory building.
It is part of a growing life sciences cluster in and around Liverpool, one of the largest in Europe, and a leader in vaccine development and manufacture, as well as infectious disease research projects in the UK.